Expert Insights Healthcare ETFs: From Broad Exposure to Big Breakthroughs By Roxanna Islam, CFA, CAIAJune 11, 2026
Beyond Basic Beta Content Hub Top Pharmaceutical Companies Shaping the Future of Healthcare By VanEckNovember 1, 2025
Beyond Basic Beta Content Hub PPH Is a Pertinent Healthcare Idea for 2025 By Todd ShriberDecember 19, 2024
Beyond Basic Beta Content Hub Healthcare ETFs Starting to Look Healthy By Todd ShriberOctober 1, 2024
Expert Insights DoubleLine’s Jeffrey Gundlach on the Fed, Gold and Private Credit By Kirsten ChangSeptember 23, 2024
Beyond Basic Beta Content Hub This Pharma ETF Could Be Ideal Healthcare Pick By Todd ShriberSeptember 3, 2024
Disruptive Technology Content Hub Disruptive Theme of the Week: Playing Defense By Jane EdmondsonAugust 14, 2024
Disruptive Technology Content Hub Thematic ETF Winners of the Q1 2024 Earnings Season By Jane EdmondsonMay 7, 2024
Beyond Basic Beta Content Hub Weight-Loss Drugs Boost Case for Pharma ETFs By Todd ShriberApril 30, 2024
Beyond Basic Beta Content Hub Weight Loss Drugs Could Prove Potent for PPH By Todd ShriberSeptember 11, 2023
Beyond Basic Beta Content Hub Growth, Innovation Could Fuel Pharma ETF Rebound By Tom LydonDecember 21, 2022
Beyond Basic Beta Content Hub PPH Is Home to Some of the Top Healthcare Stocks By Tom LydonOctober 18, 2022
Beyond Basic Beta Content Hub Pharma Stocks, ETFs Can Deal With Drug Pricing Legislation By Tom LydonJuly 27, 2022
Beyond Basic Beta Content Hub Pharmaceuticals Stocks, ETFs Could Have Power Beyond 2022 By Tom LydonFebruary 4, 2022
Beyond Basic Beta Content Hub Pharma Could Be Place to Be for Healthcare Winners, Value By Tom LydonJanuary 7, 2022
